Michael S. Poirier - 11 Jul 2022 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
Chairman and CEO, Director
Signature
/s/ Michael S. Poirier
Issuer symbol
QLGN
Transactions as of
11 Jul 2022
Net transactions value
$0
Form type
4
Filing time
04 Aug 2022, 16:16:11 UTC
Previous filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLGN Stock Option (Right to Buy) Award $0 +375,000 $0.000000 375,000 11 Jul 2022 Common Stock 375,000 $0.5136 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the stock option vest over three years in equal annual installments from the date of grant.